[go: up one dir, main page]

BR0010658A - Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida - Google Patents

Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida

Info

Publication number
BR0010658A
BR0010658A BR0010658-5A BR0010658A BR0010658A BR 0010658 A BR0010658 A BR 0010658A BR 0010658 A BR0010658 A BR 0010658A BR 0010658 A BR0010658 A BR 0010658A
Authority
BR
Brazil
Prior art keywords
methoxy
benzamide
ethyl
sodium salt
crystalline forms
Prior art date
Application number
BR0010658-5A
Other languages
English (en)
Inventor
Heinrich Christian Englert
Uwe Gerlach
Tobias Metzenthin
Harald Schneider
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0010658A publication Critical patent/BR0010658A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "FORMAS CRISTALINAS DE SAL DE SóDIO DE 5-CLORO-2-METóXI-N-(2-(4-METóXI-3-METILAMINOTIOCARBO NILAMINOSSULFONILFENIL)ETIL)BENZAMIDA". A presente invenção refere-se a formas cristalinas do sal de sódio de 5-cloro-2-metóxi-N-(2-(4-metóxi-3-metilaminotiocarbonilaminossulfonil fenil)etil)benzamida, processos para sua preparação, seu uso e preparações farmacêuticas compreendendo as mesmas.
BR0010658-5A 1999-04-16 2000-04-04 Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida BR0010658A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (de) 1999-04-16 1999-04-16 Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
PCT/EP2000/002984 WO2000063167A1 (en) 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide

Publications (1)

Publication Number Publication Date
BR0010658A true BR0010658A (pt) 2002-02-19

Family

ID=7904803

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010658-5A BR0010658A (pt) 1999-04-16 2000-04-04 Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida

Country Status (33)

Country Link
US (1) US6723751B1 (pt)
EP (2) EP1637519B1 (pt)
JP (1) JP4662640B2 (pt)
KR (1) KR100700302B1 (pt)
CN (1) CN1168712C (pt)
AR (1) AR023479A1 (pt)
AT (2) ATE311364T1 (pt)
AU (1) AU773246B2 (pt)
BR (1) BR0010658A (pt)
CA (1) CA2370388C (pt)
CZ (1) CZ302459B6 (pt)
DE (3) DE19917233A1 (pt)
DK (1) DK1173418T3 (pt)
EE (1) EE04612B1 (pt)
ES (1) ES2251996T3 (pt)
HK (1) HK1046270B (pt)
HR (1) HRP20010744B1 (pt)
HU (1) HU229082B1 (pt)
IL (2) IL145921A0 (pt)
ME (1) MEP55708A (pt)
MX (1) MXPA01010275A (pt)
MY (1) MY122588A (pt)
NO (1) NO327798B1 (pt)
NZ (1) NZ514788A (pt)
PL (1) PL203809B1 (pt)
RS (1) RS50916B (pt)
RU (1) RU2235089C2 (pt)
SI (1) SI1173418T1 (pt)
SK (1) SK287175B6 (pt)
TR (2) TR200501142T2 (pt)
TW (1) TWI276622B (pt)
WO (1) WO2000063167A1 (pt)
ZA (1) ZA200108400B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004082593A2 (en) * 2003-03-17 2004-09-30 Japan Tobacco Inc. Pharmaceutical compositions of cetp inhibitors
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59401361D1 (de) * 1993-02-23 1997-02-06 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
IL141414A0 (en) * 1998-09-10 2002-03-10 Aventis Pharma Gmbh Use of benzenesulfonyl (thio) ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl (thio) ureas in combination with beta-receptor blockers

Also Published As

Publication number Publication date
AU4542800A (en) 2000-11-02
DK1173418T3 (da) 2006-04-10
US6723751B1 (en) 2004-04-20
HK1046270A1 (en) 2003-01-03
HUP0200791A2 (hu) 2002-07-29
TWI276622B (en) 2007-03-21
HU229082B1 (hu) 2013-07-29
MXPA01010275A (es) 2003-07-21
CA2370388C (en) 2009-10-13
RS50916B (sr) 2010-08-31
HK1046270B (zh) 2005-03-11
HRP20010744A2 (en) 2003-04-30
EP1173418B1 (en) 2005-11-30
TR200501142T2 (tr) 2005-08-22
YU72001A (sh) 2004-07-15
SK287175B6 (sk) 2010-02-08
SI1173418T1 (sl) 2006-02-28
ATE311364T1 (de) 2005-12-15
WO2000063167A1 (en) 2000-10-26
IL145921A (en) 2006-07-05
EP1173418A1 (en) 2002-01-23
SK14582001A3 (sk) 2002-01-07
HRP20010744B1 (en) 2010-08-31
PL351245A1 (en) 2003-04-07
MY122588A (en) 2006-04-29
CN1354744A (zh) 2002-06-19
EP1637519A1 (en) 2006-03-22
EE04612B1 (et) 2006-04-17
PL203809B1 (pl) 2009-11-30
AU773246B2 (en) 2004-05-20
CZ20013672A3 (cs) 2002-01-16
ATE414059T1 (de) 2008-11-15
KR100700302B1 (ko) 2007-03-29
KR20010109355A (ko) 2001-12-08
RU2235089C2 (ru) 2004-08-27
TR200102993T2 (tr) 2002-03-21
ZA200108400B (en) 2003-04-30
EE200100532A (et) 2002-12-16
ES2251996T3 (es) 2006-05-16
NO327798B1 (no) 2009-09-28
DE60040811D1 (de) 2008-12-24
CA2370388A1 (en) 2000-10-26
JP2002542230A (ja) 2002-12-10
CN1168712C (zh) 2004-09-29
CZ302459B6 (cs) 2011-06-01
AR023479A1 (es) 2002-09-04
HUP0200791A3 (en) 2005-04-28
IL145921A0 (en) 2002-07-25
MEP55708A (en) 2011-05-10
NO20015014D0 (no) 2001-10-15
NO20015014L (no) 2001-10-15
DE60024431T2 (de) 2006-07-27
DE19917233A1 (de) 2000-10-19
JP4662640B2 (ja) 2011-03-30
NZ514788A (en) 2003-03-28
EP1637519B1 (en) 2008-11-12
DE60024431D1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0108678A (pt) Novos compostos
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
BR0016227A (pt) Derivados de adamantano
BR0111667A (pt) Novos compostos
BR0214469A (pt) 17alfa-alquil-17beta-óxi-estratrienos e produtos intermediários para sua preparação, aplicação dos 17alfa-alquil-17beta-óxi-estratrienos para a preparação de medicamentos bem como preparações farmacêuticas
EA200200571A1 (ru) Новая композиция и ее применение
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
BRPI0411900A (pt) compostos antivirais e métodos
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
BR9806568A (pt) Forma de cristal de n-(4-trifluormetilfenil)-5-metilisoxazol-4-carboxamida
BR0113590A (pt) 7-oxo-piridopirimidinas
BR0011700A (pt) Dinitrilas de ácido arilmalÈnico substituìdo como intermediários para a preparação de herbicidas
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BR0111669A (pt) Novos compostos
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BR0113650A (pt) N-(3,5-dicloro-2-metoxifenil)-4-metóxi-3-piperazina-1-il a-benzenossulfonamida
BR0010658A (pt) Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida
DE69828522D1 (de) Antithrombotische mittel
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
HUP0102075A2 (hu) Stabil mitoxantron-oldatok, eljárás az előállításukra
BR9106188A (pt) Novos derivados p-substituidos de fenil-4-oxibutano amina,processo para sua preparacao e composicoes farmaceuticas contendo os mesmos

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: C07C 335/42, A61K 31/18, A61P 9/06

Ipc: C07C 335/42 (2009.01), A61K 31/18 (2009.01), A61P

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 24 DA LPI INDEFIRO O PEDIDO DE ACORDO COM O(S)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 16A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.